Author

Guenther S

Greifswald University - Cited by 7,487

Biography

 Professor Guenther S currently works as a Professor at Department of Microbiology and Epizootics at Freie Universitat, Germany. His International experience include programs, contributions and participations at different countries in diverse field of study. He is the editorial board member for the Journal of Probiotics and Health and also a member of various associations.
Title
Cited by
Year
A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron …
SE Heiden, NO Hübner, JA Bohnert, CD Heidecke, A Kramer, V Balau, ...Genome Medicine 12, 1-15, 2020202
66
2020
The potential of using E. coli as an indicator for the surveillance of antimicrobial resistance (AMR) in the environment
MF Anjum, H Schmitt, S Börjesson, TU Berendonk, E Donner, EG Stehling, ...Current Opinion in Microbiology 64, 152-158, 2021202
46
2021
Inactivation of airborne bacteria by plasma treatment and ionic wind for indoor air cleaning
F Prehn, E Timmermann, M Kettlitz, K Schaufler, S Günther, V HahnPlasma Processes and Polymers 17 (9), 2000027, 2020202
26
2020
Phenotypic zinc resistance does not correlate with antimicrobial multi-resistance in fecal E. coli isolates of piglets
F Ghazisaeedi, L Ciesinski, C Bednorz, V Johanns, L Pieper, K Tedin, ...Gut pathogens 12 (1), 1-10, 2020202
19
2020
Income and housing satisfaction and their association with self-rated health in different life stages. A fixed effects analysis using a German panel study
A Knoechelmann, N Seifert, S Guenther, I Moor, M RichterBMJ open 10 (6), e034294, 2020202
16
2020
Synergistic antimicrobial activities of epigallocatechin gallate, myricetin, daidzein, gallic acid, epicatechin, 3‐hydroxy‐6‐methoxyflavone and genistein combined with …
D Buchmann, N Schultze, J Borchardt, I Böttcher, K Schaufler, S GuentherJournal of Applied Microbiology 132 (2), 949-963, 2022202
14
2022
Extensively drug-resistant Klebsiella pneumoniae counteracts fitness and virulence costs that accompanied ceftazidime-avibactam resistance acquisition
E Eger, M Schwabe, L Schulig, NO Hübner, JA Bohnert, UT Bornscheuer, ...Microbiology Spectrum 10 (3), e00148-22, 2022202
13
2022
Genomic and Phenotypic Analysis of an ESBL-Producing E. coli ST1159 Clonal Lineage From Wild Birds in Mongolia
P Schierack, SE Heiden, MM Khan, L Nikolaus, R Kolenda, M Stubbe, ...Frontiers in Microbiology 11, 1699, 2020202
12
2020
Frequency, Local Dynamics, and Genomic Characteristics of ESBL-Producing Escherichia coli Isolated From Specimens of Hospitalized Horses
A Kauter, L Epping, F Ghazisaeedi, A Lübke-Becker, SA Wolf, D Kannapin, ...Frontiers in Microbiology 12, 671676, 2021202
9
2021
Molecular basis of selective cytokine signaling inhibition by antibodies targeting a shared receptor
JK Fields, K Kihn, GS Birkedal, EH Klontz, K Sjöström, S Günther, ...Frontiers in Immunology 12, 77100, 2021202
9
2021
Ethiopian Medicinal Plants traditionally used for the treatment of cancer; Part 3: selective cytotoxic activity of 22 Plants against human cancer Cell Lines
S Tesfaye, H Braun, K Asres, E Engidawork, A Belete, I Muhammad, ...Molecules 26 (12), 3658, 2021202
7
2021
Social mobility, accumulation of disadvantages and health. An analysis with retrospective data from the GSOEP (2002–14)
A Knöchelmann, S Günther, I Moor, N Seifert, M RichterEuropean Journal of Public Health 30 (1), 98-104, 2020202
7
2020
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
V Srinivasan, H Brognaro, PR Prabhu, EE de Souza, S Günther, ...Communications Biology 5 (1), 805, 2022202
7
2022
Impact of different management measures on the colonization of broiler chickens with ESBL- and pAmpC- producing Escherichia coli in an experimental seeder …
C Robé, K Daehre, R Merle, A Friese, S Guenther, U RoeslerPLoS One 16 (1), e024224, 2021202
5
2021
SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design
V Srinivasan, H Brognaro, PR Prabhu, EE de Souza, S Günther, ...Biorxiv, 2021.11. 17.468943, 2021202
5
2021
Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
J Seeger, S Guenther, K Schaufler, SE Heiden, R Michelet, C KloftAntibiotics 10 (6), 615, 2021202
4
2021
Evaluating Tannins and Flavonoids from Traditionally Used Medicinal Plants with Biofilm Inhibitory Effects against MRGN E. coli
N Neumann, M Honke, M Povydysh, S Guenther, C SchulzeMolecules 27 (7), 228, 2022202
4
2022
X-ray structure of the Rhodobacter sphaeroides reaction center with an M197 Phe→ His substitution clarifies the properties of the mutant complex
G Selikhanov, T Fufina, S Guenther, A Meents, A Gabdulkhakov, ...IUCrJ 9 (2), 261-271, 2022202
4
2022
Hydrazones and thiosemicarbazones targeting protein-protein-interactions of SARS-CoV-2 papain-like protease
W Ewert, S Günther, F Miglioli, S Falke, PYA Reinke, S Niebling, ...Frontiers in Chemistry 10, 83231, 2022202
4
2022
Antibiofilm Activity of Sundew Species against Multidrug-Resistant Escherichia coli Strains
S Gerschler, S Guenther, C SchulzeInternational Journal of Molecular Sciences 23 (22), 13720, 2022202
4
2022

Referred From: https://scholar.google.com/citations?user=Rp3WRHEAAAAJ&hl=en

Cited by
Citations 7487
h-index 49
i10-index 94
Recommended Journals
Open Access Journals